Skip to main content
Clinical Trials/NCT06512662
NCT06512662RecruitingNot Applicable

Support Pathway for ENT Cancer Patients in a Support Care Day Hospital Single-centre Prospective Randomised Interventional Study

Clinique Pasteur Lanroze1 site in 1 country60 target enrollmentStarted: October 8, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
60
Locations
1
Primary Endpoint
Anxiety

Study Overview

Brief Summary

Cancers of the upper respiratory / digestive tract are a major public health problem, ranking 5th among the most common cancers. Surgery plays a central role in the recommended treatments for this type of pathology. The surgical procedure and its after-effects can be anxiety-provoking and have a major psychological, physical and social impact on patients over the long term.

Our institution's standard protocol is based on a pre-operative supportive care day hospital. The aim of this study is to compare our current care pathway with a more extensive interdisciplinary care pathway focused on patients' needs, in order to reduce anxiety and improve the quality of life of patients undergoing surgery for cancers of the upper respiratory / digestive tract.

Our aim is to use a prospective single-centre interventional study to assess the impact of adding three post-operative day hospitals to the existing care pathway in terms of reducing anxiety and improving the quality of life of patients undergoing surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patient undergoing surgery for VADS cancer requiring at least one night's post-operative hospitalisation
  • •Understanding of spoken and written French
  • •Patient covered by a social security scheme

Exclusion Criteria

  • •Protected patient under a protective measure or legal safeguard
  • •Pregnant or breast-feeding patients
  • •Patients suffering from major cognitive disorders
  • •Patients with major anxiety disorders prior to the onset of cancer

Arms & Interventions

Control

No Intervention

Supportive care

Experimental

Intervention: Consultations with paramedics (Procedure)

Outcomes

Primary Outcomes

Anxiety

Time Frame: 1 month ; 3 months ; 6 months

Anxiety evaluation by State Trait Anxiety Inventory (STAI) scale. It is a psychological inventory consisting of 40 self-report items on a 4-point Likert scale. The STAI measures two types of anxiety - state anxiety and trait anxiety. Higher scores are positively correlated with higher levels of anxiety.

Secondary Outcomes

  • Quality of life evaluation(1 month ; 3 months ; 6 months)
  • pain evaluation(1 month ; 3 months ; 6 months)
  • Toxic behaviour (tobacco and alcohol) evaluation(1 month ; 3 months ; 6 months)
  • Weight status evaluation(1 month ; 3 months ; 6 months)
  • nutritional status evaluation(1 month ; 3 months ; 6 months)
  • swallowing assessment(1 month ; 3 months ; 6 months)
  • vocal status assessment(1 month ; 3 months ; 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Support Pathway for ENT Cancer Patients in... | Clinical Trial